Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 10/20 | 0.64 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.62 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.52 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.52 |
| ▸ | PPARD | Q03181 | 6/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.50 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 5/20 | 0.48 |
| ▸ | PPARA | Q07869 | 5/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10386196 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD | |
| SCHEMBL8049901 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD | |
| SCHEMBL951973 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD | |
| SCHEMBL5710467 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD | |
| SCHEMBL248934 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD | |
| SCHEMBL23930717 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD | |
| SCHEMBL3423500 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD | |
| SCHEMBL22612526 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD | |
| SCHEMBL22612511 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD | |
| SCHEMBL11940342 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250320174-A1 | SPIN ON METAL-ORGANIC FORMULATIONS | MERCK PATENTS GMBH (DE) | 2025-10-16 | — | — | US | claimed |
| US-20250057798-A1 | THERAPEUTIC USE OF COMPOUNDS | UCL BUSINESS LTD (GB) | 2025-02-20 | — | — | US | claimed |
| CN-117380269-B | Oil-soluble organic molybdenum catalyst and preparation method and application thereof | 北京高新利华科技股份有限公司 | 2024-04-05 | — | — | CN | claimed |
| EP-4334252-A2 | SPIN ON METAL-ORGANIC FORMULATIONS | Merck Patent GmbH (DE) | 2024-03-13 | — | — | EP | claimed |
| CN-117380269-A | Oil-soluble organic molybdenum catalyst and preparation method and application thereof | 北京高新利华科技股份有限公司 | 2024-01-12 | — | — | CN | claimed |
| CN-117295693-A | Spin-on metal-organic formulations | 默克专利股份有限公司 | 2023-12-26 | — | — | CN | claimed |
| US-20230146709-A1 | THERAPEUTIC USE OF COMPOUNDS | UCL BUSINESS LTD (GB) | 2023-05-11 | — | — | US | claimed |
| WO-2022233919-A2 | SPIN ON METAL-ORGANIC FORMULATIONS | MERCK PATENT GMBH (DE) | 2022-11-10 | — | — | WO | claimed |
| US-11246823-B2 | Molecularly imprinted polymer of sol-gel type for selectively trapping odorous molecules | L'OREAL (FR) | 2022-02-15 | — | — | US | claimed |
| US-20200268699-A1 | THERAPEUTIC USE OF COMPOUNDS | UCL BUSINESS LTD (GB) | 2020-08-27 | — | — | US | claimed |
| WO-2014102078-A1 | MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | L'OREAL (FR) | 2014-07-03 | — | — | WO | claimed |
| WO-2014102077-A1 | MOLECULARLY IMPRINTED POLYMER FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | L'OREAL (FR) | 2014-07-03 | — | — | WO | claimed |
| US-20130303616-A1 | THERAPEUTIC USE OF COMPOUNDS | UCL BUSINESS PLC (GB) | 2013-11-14 | — | — | US | claimed |
| US-20130203766-A1 | Pharmaceutical Compositions for the Treatment of Sexual Disorders II | SPROUT PHARMACEUTICALS, INC. (US) | 2013-08-08 | — | — | US | claimed |
| US-20110105519-A1 | Pharmaceutical Compositions for the Treatment of Sexual Disorders II | SPROUT PHARMACEUTICALS, INC. | 2011-05-05 | — | — | US | claimed |
| US-20080103155-A1 | Pharmaceutical compositions for the treatment of sexual disorders II | SPROUT PHARMACEUTICALS, INC. | 2008-05-01 | — | — | US | claimed |
| US-20050245539-A1 | Pharmaceutical compositions for the treatment of sexual disorders II | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-11-03 | — | — | US | claimed |
| CN-1530362-A | Preparation of acid by alpha-chlorination of epoxy resin | ʷ��˿�������ȳ�ķ����˾ | 2004-09-22 | — | — | CN | claimed |
| US-20040044080-A1 | Treatment of dyspareunia with topically administered nitroglycerin formulations | VIVUS, INC. | 2004-03-04 | — | — | US | claimed |
| CN-1368955-A | Method for producing acids by means of alpha-chloroepoxy esters | SMITHKLINE BEECHAM CORP (US) | 2002-09-11 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230146709-A1 | THERAPEUTIC USE OF COMPOUNDS | SGMS1, CHRM1, CYP11B1 | GPR84 839/4885ACE2 2018/4885FFAR1 85/4885 |
| US-20200268699-A1 | THERAPEUTIC USE OF COMPOUNDS | DEGS1, CYP11B1, SGMS1 | GPR84 1057/4885ACE2 2571/4885FFAR1 149/4885 |
| US-20080103155-A1 | Pharmaceutical compositions for the treatment of sexual disorders II | FLNB, FLNA, FGB | GPR84 974/4885ACE2 2597/4885FFAR1 594/4885 |
| US-20250320174-A1 | SPIN ON METAL-ORGANIC FORMULATIONS | SLC39A11, SLC39A3, SLC39A7 | GPR84 4523/4885ACE2 2841/4885FFAR1 3654/4885 |
| US-20130303616-A1 | THERAPEUTIC USE OF COMPOUNDS | BACE1, CPT1A, BCL6 | GPR84 849/4885ACE2 2880/4885FFAR1 194/4885 |
| US-20250057798-A1 | THERAPEUTIC USE OF COMPOUNDS | CYP11B1, SGMS1, PTGER1 | GPR84 630/4885ACE2 1765/4885FFAR1 66/4885 |
| US-11246823-B2 | Molecularly imprinted polymer of sol-gel type for selectively trapping odorous molecules | TAS2R30, TAS1R1, TAS2R10 | GPR84 471/4885ACE2 4321/4885FFAR1 2567/4885 |
| US-20130203766-A1 | Pharmaceutical Compositions for the Treatment of Sexual Disorders II | FLNB, FLNA, FGB | GPR84 974/4885ACE2 2597/4885FFAR1 594/4885 |
| US-20110105519-A1 | Pharmaceutical Compositions for the Treatment of Sexual Disorders II | FLNB, FLNA, FGB | GPR84 974/4885ACE2 2597/4885FFAR1 594/4885 |
| US-20040044080-A1 | Treatment of dyspareunia with topically administered nitroglycerin formulations | PDE12, PDE3A, PDE2A | GPR84 212/4885ACE2 1720/4885FFAR1 489/4885 |
| US-20050245539-A1 | Pharmaceutical compositions for the treatment of sexual disorders II | FLNB, FLNA, FGB | GPR84 974/4885ACE2 2597/4885FFAR1 594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.